This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Spears, C. P. Articles by Hayes, A. A. Search for Related Content PubMed PubMed Citation Articles by Spears, C. P. Articles by Hayes, A. A.

Mechanisms of Innate Resistance to Thymidylate Synthase Inhibition after 5-Fluorouracil¹

The University of Southern California Comprehensive Cancer Center, Los Angeles, California [C. P. S., A. A. H.], and the Department of Surgery, Östra Hospital, University of Göteborg, Göteborg, Sweden [B. G. G., M. B., R. F.]

Fifty-four patients with metastatic adenocarcinoma received i.v. bolus 5-fluorouracil, 500 mg/m², prior to surgical biopsy of tumor at 20–400 min, for analysis of biochemical parameters of resistance to thymidylate synthase (TS) inhibition. The majority of patients, 37, had colon or rectal adenocarcinoma, five had breast cancer, five had gastric primary disease, four had pancreatic adenocarcinoma, and three had hepatocellular adenocarcinoma. Fluorodeoxyuridylate (FdUMP) was assayed by isotope dilution of [³H]FdUMP binding to bacterial TS; free and total TS was determined by [³H]FdUMP binding; and deoxyuridylate (dUMP) was assayed by conversion to [¹⁴C]thymidylate. Free levels of TS were lower in breast cancers, 0.08 ± 0.06 pmol/g, than in other histologies (overall average, 1.41 ± 2.25), associated with significantly greater percentages of TS inhibition (88.6% versus 62.0% overall). Colorectal tumors showed significantly greater FdUMP levels than other gastrointestinal malignancies, associated with somewhat lower free TS values. Plots of FdUMP levels, or (FdUMP/dUMP) ¢ 100 values versus percentages of TS inhibition suggested minima of 75 pmol/g and 0.10, respectively, for achieving maximal enzyme inhibition. Analyses of normal tissues showed: poor TS inhibition in liver and normal colonic mucosa, related to low FdUMP levels; and very high dUMP levels in bone marrow leukocytes suggestive of reactive increases in dUMP as an important mechanism of recovery in this tissue. Among the 30 of the 37 colorectal tumors that showed suboptimal (less than 85%) inhibition of TS, 16 (53%) showed FdUMP levels less than 75 pmol/g, 8 (27%) showed relatively high dUMP levels (over 35 nmol/g), and 16 (53%) showed poor efficiency of inhibition of TS, with the major overlap between these mechanisms of resistance being high dUMP and poor binding in 6 (20%). These data provide a strong rationale for administration of leucovorin to the majority of patients receiving 5-fluorouracil, since increased intratumoral reduced folates potentially can overcome multiple mechanisms of resistance including low FdUMP, high dUMP, and high total TS levels, in addition to that caused by isolated folate deficiency.

¹ This work was supported by NIH Grant CA39629 awarded to C. P. S., and by funding from the Swedish Research Society to B. G. G.

² To whom requests for reprints should be addressed, at University of Southern California, Comprehensive Cancer Center, Cancer Research Laboratory—Lab 206, 1303 North Mission Road, Los Angeles, CA 90033.

Received 1/20/88. Revised 6/ 1/88. Accepted 7/20/88.

This article has been cited by other articles:

				T. Okabe, I. Okamoto, S. Tsukioka, J. Uchida, T. Iwasa, T. Yoshida, E. Hatashita, Y. Yamada, T. Satoh, K. Tamura, et al. Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase Mol. Cancer Ther., March 1, 2008; 7(3): 599 - 606. [Abstract] [Full Text] [PDF]

				Y.-K. Shin, B. C. Yoo, H. J. Chang, E. Jeon, S.-H. Hong, M.-S. Jung, S.-J. Lim, and J.-G. Park Down-regulation of Mitochondrial F1F0-ATP Synthase in Human Colon Cancer Cells with Induced 5-Fluorouracil Resistance Cancer Res., April 15, 2005; 65(8): 3162 - 3170. [Abstract] [Full Text] [PDF]

				B. C. Yoo, E. Jeon, S.-H. Hong, Y.-K. Shin, H. J. Chang, and J.-G. Park Metabotropic Glutamate Receptor 4-Mediated 5-Fluorouracil Resistance in a Human Colon Cancer Cell Line Clin. Cancer Res., June 15, 2004; 10(12): 4176 - 4184. [Abstract] [Full Text] [PDF]

				R. Sowers, J. Toguchida, J. Qin, P. A. Meyers, J. H. Healey, A. Huvos, D. Banerjee, J. R. Bertino, and R. Gorlick mRNA Expression Levels of E2F Transcription Factors Correlate with Dihydrofolate Reductase, Reduced Folate Carrier, and Thymidylate Synthase mRNA Expression in Osteosarcoma Mol. Cancer Ther., June 1, 2003; 2(6): 535 - 541. [Abstract] [Full Text] [PDF]

				H H J Backus, C J Van Groeningen, W Vos, D F Dukers, E Bloemena, D Wouters, H M Pinedo, and G J Peters Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases J. Clin. Pathol., March 1, 2002; 55(3): 206 - 211. [Abstract] [Full Text] [PDF]

				K. Nakakuki, I. Imoto, A. Pimkhaokham, Y. Fukuda, Y. Shimada, M. Imamura, T. Amagasa, and J. Inazawa Novel targets for the 18p11.3 amplification frequently observed in esophageal squamous cell carcinomas Carcinogenesis, January 1, 2002; 23(1): 19 - 24. [Abstract] [Full Text] [PDF]

				G. Schwartz, T. R. Johnson, A. Goetz, H. Burris, L. Smetzer, T. Lampkin, J. Sailstad, J. A. Hohneker, D. D. Von Hoff, and E. K. Rowinsky A Phase I and Pharmacokinetic Study of 1843U89, a Noncompetitive Inhibitor of Thymidylate Synthase, in Patients with Advanced Solid Malignancies Clin. Cancer Res., July 1, 2001; 7(7): 1901 - 1911. [Abstract] [Full Text] [PDF]

				J. R. Bading, M. M. Alauddin, J. D. Fissekis, A. H. Shahinian, J. Joung, T. Spector, and P. S. Conti Blocking Catabolism with Eniluracil Enhances PET Studies of 5-[18F]Fluorouracil Pharmacokinetics J. Nucl. Med., October 1, 2000; 41(10): 1714 - 1724. [Abstract] [Full Text] [PDF]

				M. Kasahara, Y. Takahashi, T. Nagata, S. Asai, T. Eguchi, Y. Ishii, M. Fujii, and K. Ishikawa Thymidylate Synthase Expression Correlates Closely with E2F1 Expression in Colon Cancer Clin. Cancer Res., July 1, 2000; 6(7): 2707 - 2711. [Abstract] [Full Text]

				J. J. Rusthoven, E. Eisenhauer, C. Butts, R. Gregg, J. Dancey, B. Fisher, and J. Iglesias Multitargeted Antifolate LY231514 as First-Line Chemotherapy for Patients With Advanced Non-Small-Cell Lung Cancer: A Phase II Study J. Clin. Oncol., April 1, 1999; 17(4): 1194 - 1194. [Abstract] [Full Text] [PDF]

				E. L. Schwartz, N. Baptiste, S. Wadler, and D. Makower Thymidine Phosphorylase Mediates the Sensitivity of Human Colon Carcinoma Cells to 5-Fluorouracil J. Biol. Chem., August 11, 1995; 270(32): 19073 - 19077. [Abstract] [Full Text] [PDF]